Skip to content
10-K

Annual Report

Enumeral Biomedical Holdings, Inc.

0001615774-17-001281

← back to feed
Filed
Mar 28, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Mar 24, 2017 128.41M sh
Shares Diluted FY 2016 · Dec 31, 2016 56.19M sh
Shares Diluted FY 2016 · Dec 31, 2015 52.37M sh
Cash And Equivalents FY 2016 · Dec 31, 2016 $3.16M
Cash And Equivalents FY 2016 · Dec 31, 2015 $3.6M
Cash And Equivalents FY 2016 · Dec 31, 2014 $10.46M
Stockholders Equity FY 2016 · Dec 31, 2016 $3.91M
Stockholders Equity FY 2016 · Dec 31, 2015 $2.47M
Stockholders Equity FY 2016 · Dec 31, 2014 −$1.68M
Current Liabilities FY 2016 · Dec 31, 2016 $961.35K
Current Liabilities FY 2016 · Dec 31, 2015 $3.57M
Total Liabilities FY 2016 · Dec 31, 2016 $1.04M
Total Liabilities FY 2016 · Dec 31, 2015 $3.87M
Current Assets FY 2016 · Dec 31, 2016 $3.4M
Current Assets FY 2016 · Dec 31, 2015 $4.18M
Total Assets FY 2016 · Dec 31, 2016 $4.95M
Total Assets FY 2016 · Dec 31, 2015 $6.34M
Eps Diluted FY 2016 · Dec 31, 2016 −$0.21
Eps Diluted FY 2016 · Dec 31, 2015 $0.06
Eps Basic FY 2016 · Dec 31, 2016 −$0.21
Eps Basic FY 2016 · Dec 31, 2015 $0.06
Sga Expense FY 2016 · Dec 31, 2016 $4.56M
Sga Expense FY 2016 · Dec 31, 2015 $5.7M
Rd Expense FY 2016 · Dec 31, 2016 $4.87M
Rd Expense FY 2016 · Dec 31, 2015 $6.49M
Net Income FY 2016 · Dec 31, 2016 −$11.86M
Net Income FY 2016 · Dec 31, 2015 $3.29M
Operating Income FY 2016 · Dec 31, 2016 −$6.97M
Operating Income FY 2016 · Dec 31, 2015 −$10.7M
Capex FY 2016 · Dec 31, 2015 $1.05M